MESTEROLONE (PROVIRON) (25 MG/TAB. – 50 TABS)

Description

Mesterolone

Strength: 25 mg
Molecular Formula: C20H3202
Molecular Weight: 304.46688 g/mol
Active Ingredient: Mesterolone
CAS number: 1424-00-6
Dosage Form: Tablet
Route: Oral Market Status: Prescription
Company: Hilma Biocare

DESCRIPTION

Mesterolone 25 is used to treat potency disturbances, infertility, and declining physical and
mental M alertness in the aging male due to reduced androgen formation. It is an oral
androgen which does not aromatize estrogen. It does not stimulate the body to produce
testosterone but may act as an oral androgen substitute to compensate for a lack of the
natural male androgen. It is suitable för treatment of all conditions caused by deficient
endogenous androgen formation without impairment of spermato- genesis. It is effective as
an anti-aromatase in the body, preventing or slowing the conversion of androgens into
estrogens. Mesterolone 25 is well tolerated by the liver.

CLINICAL PHARMACOLOGY

Mesterolone balances a deficiency of androgen formation, which begins to fall gradually with
increasing age. It is used to treat various types of sexual dysfunction often resulting from low
endogenous testosterone production. Mesterolone can in many cases reverse problems of
sexual disinterest and impotency and is sometimes used to increase the sperm count.
Mesterolone is suitable for treatment of all conditions caused by deficient endogenous
androgen formation. In the recommended therapeutic dosage, Mesterolone will not impair
spermatogenesis. Mesterolone is well tolerated by the liver.

INDICATION

Declining physical activity and mental alertness in the aging male: reduced efficiency, easy
fatigability, lack of concentration, weak memory, disturbances of libido and potency,
irritability, disturbances of sleep, depressive moods, and general vegetative complaints often
attributed to androgen-deficiency are often overcome or improved with Mesterolone 25 use.
Potency Disturbances: Mesterolone overcomes androgen-deficiency linked potency
disturbances and may provide improvement in cases of potency disturbance which are not
androgen-deficiency linked. Hypogonadism: Function and growth of androgen- dependent
tissues are stimulated by Mesterolone. It may be used for androgen replacement therapy
after puberty. Reduction of Sex hormone- binding globulin (SHBG) increasing free
testosterone levelsoem Infertility: Treatment of oligozoospermia and insufficient Leydig-cell
secretion linked infertility. Treatment can increase sperm count, quality, and fructose
concentration increasing chances of fertilization.

CONTRAINDICATIONS

Patients with carcinoma or suspected carcinoma of the prostate or testis should not undergo
androgen therapy of any kind including the use of Mesterolone 25.

PRECAUTIONS

Mesterolone 25 is recommended only for male patients. Regular examinations of the
prostate should be carried out prophylactically.

ADVERSE REACTIONS

Oily skin, increased body hair growth, possible hair loss at higher doses if genetically
predisposed.

DOSAGE AND ADMINISTRATION

Declining physical activity and potency issues: One 25mg tablet taken orally 3 times per day
for the first week and thereafter one 25mg tablet taken orally 1 to 2 times per day for a
duration from 4 to 6 weeks to several months.

Hypogonadism: One 25mg tablet taken orally 2 to 3 times daily.

Oligozoospermia: One 25mg tablet taken orally 2 to 3 times daily for a full spermatogenic cycle (3 months).

PRESENTATION

Mesterolone 25 mg uncoated tablets: 50 tablets in 1 bottle.

STORAGE

Store in a cool dry place is between 15 -25°C. Protect from light.